Abstract
AbstractPolymer‐stabilized iron oxide nanoparticles could be used as contrast agents in magnetic resonance imaging (MRI) due to their unique superparamagnetism. Here we demonstrate a quaternized chitosan, i.e. N‐[(2‐hydroxy‐3‐trimethylammonium)propyl] chitosan chloride (HTCC), encapsulating superparamagnetic iron oxide (SPIO), with very low toxicity and less effect on cell growth. HTCC has quaternary amino groups introduced into the chitosan chain, and such modification of chitosan should render it soluble in water. Most importantly, the HTCC–SPIO thus prepared has the ability to accelerate the MRI relaxation processes of surrounding water protons, resulting in enhanced MRI contrast (R2: y = 0.1076x − 0.0092; R1: y = 0.008x − 0.0005). The iron content quantified by Prussian blue staining and MRI revealed a positive correlation between Prussian blue positive cells and the change of MRI signal intensity. Also, transmission electron microscopy and element mapping confirmed intracellular metal‐like spots as internalized iron oxide. Such findings support the use of these quaternized chitosan‐stabilized iron oxide nanoparticles as a potential MRI contrast agent for cell tracking. Copyright © 2011 Society of Chemical Industry
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
